首页> 美国卫生研究院文献>European Journal of Hospital Pharmacy >3PC-014 Stability study of gentamicin lock therapy with heparin or citrate as anticoagulant
【2h】

3PC-014 Stability study of gentamicin lock therapy with heparin or citrate as anticoagulant

机译:3PC-014孕肝素或柠檬酸甘露糖苷锁定治疗的稳定性研究抗凝血剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The antibiotic lock therapy (ALT) technique that involves the instillation of a highly concentrated antimicrobial solution with additives such as anticoagulants into the catheter lumen, is an option for treatment of catheter-related bloodstream infections when the central venous catheter is retained. An important limitation is the frequent incompatibility between the components, causing great controversy in the literaure. The ALT with gentamicin is one of the most requested ALT for treating bacteriemias by Gram(-). The anticoagulant that is studied more is unfractioned heparin. It can be used in haemodialysis patients, however, other anticoagulants such as citrate whose data are limited regarding compatibility should be used for patients with a history of heparin-induced trombocytopenua (HIT) or active HIT.
机译:涉及将高浓度的抗微生物溶液滴注的抗生素锁定疗法(ALT)技术,例如抗凝血剂进入导管内腔,是在保留中央静脉导管时处理导管相关的血流感染的选择。一个重要的限制是组件之间的频繁不相容,在文献中导致巨大争议。庆大霉素的Alt是由克( - )治疗菌血症最受要求的ALT之一。研究更多的抗凝血剂是未分结的肝素。然而,它可以用于血液透析患者,然而,其他抗凝血剂如柠檬酸盐,其数据有限地应用于肝素诱导的红蛋白蛋白(击中)或活跃击中的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号